首页> 外文OA文献 >Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial

【2h】

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial

机译：随机II期研究评估联合放化疗后使用替莫唑胺与原发性胶质母细胞瘤患者使用替莫唑胺放化疗后质子增强的应用：CLEOpaTRa试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Combs Stephanie E; Kieser Meinhard; Rieken Stefan; Habermehl Daniel; Jäkel Oliver; Haberer Thomas; Nikoghosyan Anna; Haselmann Renate; Unterberg Andreas; Wick Wolfgang; Debus Jürgen;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial [J] . Stephanie E Combs, Meinhard Kieser, Stefan Rieken, BMC Cancer . 2010,第1期

机译：II期随机研究评估原发性胶质母细胞瘤患者联合替莫唑胺放化疗后碳离子增强与替莫唑胺放化疗后质子增强：CLEOPATRA试验
2. Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082) [J] . Wick Wolfgang, Gorlia Thierry, Bady Pierre, Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第19期

机译：新诊断为无MGMT启动子甲基化的胶质母细胞瘤患者的放疗和替莫罗胺与放化疗联合替莫唑胺II期研究（EORTC 26082）
3. Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center,Randomized, Parallel, Open-label, Phase Ⅱ Clinical Trial [J] . Ying Mao, Yu Yao, Li-Wei Zhang, 中华医学杂志（英文版） . 2015,第020期

机译：早期替莫唑胺与伴发放化疗对新诊断的胶质母细胞瘤患者有什么益处？一项多中心，随机，平行，开放标签的Ⅱ期临床试验
4. Recruitment, retention and compliance in randomized, phase III clinical trials involving obese patients diagnosed with type 2 Diabetes Mellitus with respect to weight loss practicum report. [D] . Mithani, Moez S. 2012

机译：涉及诊断为2型糖尿病的肥胖患者的有关减肥实践的随机III期临床试验中的招募，保留和依从性报告。
5. Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial [O] . Stephanie E Combs, Meinhard Kieser, Stefan Rieken, 2010

机译：II期随机研究评估原发性胶质母细胞瘤患者联合替莫唑胺放化疗后碳离子强化与替莫唑胺放化疗后质子强化的效果：CLEOPATRA试验
6. Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial [O] . Stephanie E Combs, Meinhard Kieser, Stefan Rieken, 2010

机译：II期随机研究评估原发性胶质母细胞瘤患者联合替莫唑胺放化疗后碳离子强化与替莫唑胺放化疗后质子强化的效果：CLEOPATRA试验

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial

著录项

相似文献

相关主题

期刊订阅